Cleft lip repair (CLR) can be complicated by hypertrophic scar or keloid. Botulinum toxin type A (BTA) may improve postoperative scarring by reducing muscle tension and cytokine activity at the scar site. This systematic review analyzes the available evidence regarding the effect of BTA on scar quality after CLR.
Design
The search was conducted in 6 different databases in accordance with PRISMA guidelines (PubMed, Scielo, Embase, Scopus, Web of Science, and Cochrane) using “botulinum toxin” and “cleft lip” as keywords.
Setting
Academic hospital
Patients
Exclusive to patients who underwent CLR and BTA injection
Outcome measures
Mean visual analog scores (VAS), mean Vancouver scar scale (VSS), scar width, and BTA or CLR-related complications.
Results
Five studies for a total of 216 patients met inclusion criteria. Four studies reported on primary CLR during infancy while 1 study recruited older patients seeking revision. All patients had BTA (range: 1-2 units/kg) injected in the orbicularis oris muscle. One study documented BTA injections in additional perioral muscles. All 4 studies that measured scar width and had a saline control arm found a significant decrease in width with BTA injection. Improvement of VAS and VSS with BTA was reported in 3 of 5 studies and 2 of 5 studies, respectively. There were no reports of complications associated with BTA or CLR.
Conclusion
The existing studies support the use of BTA injection to improve scar quality following CLR with low concern for complication. Further investigations with a greater number of patients are necessary.
SalariNDarvishiNHeydariMBokaeeSDarvishiFMohammadiM. Global prevalence of cleft palate, cleft lip and cleft palate and lip: A comprehensive systematic review and meta-analysis. J Stomatol Oral Maxillofac Surg. 2022;123(2):110-120. Doi:https://doi.org/10.1016/j.jormas.2021.05.008
2.
ChangCSWallaceCGHsiaoYCChangCJChenPK. Botulinum toxin to improve results in cleft lip repair. Plast Reconstr Surg. 2014;134(3):511-516. Doi:https://doi.org/10.1097/PRS.0000000000000416
3.
SoltaniAMFrancisCSMotamedA, et al.Hypertrophic scarring in cleft lip repair: A comparison of incidence among ethnic groups. Clin Epidemiol. 2012;4(1):187-191. Doi:https://doi.org/10.2147/CLEP.S31119
4.
LiuRKLiCHZouSJ. Reducing scar formation after lip repair by injecting botulinum toxin. Plast Reconstr Surg. 2010;125(5):1573-1574. Doi:https://doi.org/10.1097/PRS.0b013e3181d51404
5.
ThompsonJAHeatonPCKeltonCMSitzmanTJ. National estimates of and risk factors for inpatient revision surgeries for orofacial clefts. Cleft Palate Craniofac J. 2017;54(1):60-69. Doi:https://doi.org/10.1597/15-206
6.
Al-QattanMMAl-ShanawaniBNAlshomerF. Botulinum toxin type A: Implications in wound healing, facial cutaneous scarring, and cleft lip repair. Ann Saudi Med. 2013;33(5):482-488. Doi:https://doi.org/10.5144/0256-4947.2013.482
7.
ManriqueMBryantJRBenitezEMantilla-RivasERogersGFOhAK. William H. G. Logan and His Bow. Plast Reconstr Surg Glob Open. 2020;8(5):e2795. Doi:https://doi.org/10.1097/GOX.0000000000002795
SchweigerESRiddleCCTonkovic-CapinVAiresDJ. Successful treatment with injected hyaluronic acid in a patient with lip asymmetry after surgical correction of cleft lip. Dermatol Surg. 2008;34(5):717-719. Doi:https://doi.org/10.1111/j.1524-4725.2008.34133.x
11.
LennerstrandGNordbøOATianSEriksson-DerouetBAliT. Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol Scand. 1998;76(1):27-37. Doi:https://doi.org/10.1034/j.1600-0420.1998.760106.x
12.
BruloyESinnaRGrolleauJLBout-RoumazeillesABerardEChaputB. Botulinum toxin versus placebo: A meta-analysis of prophylactic treatment for migraine. Plast Reconstr Surg. 2019;143(1):239-250. Doi:https://doi.org/10.1097/PRS.0000000000005111
GassnerHGSherrisDAOtleyCC. Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Plast Reconstr Surg. 2000;105(6):1948-1955. Doi:https://doi.org/10.1097/00006534-200005000-00005
15.
SchniderPBinderMAuffEKittlerHBergerTWolffK. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol. 1997;136(4):548-552.
16.
ComellaCLJankovicJBrinMF. Use of botulinum toxin type A in the treatment of cervical dystonia. Neurology. 2000;55(12 Suppl 5):S15-S21.
17.
SilbersteinSMathewNSaperJJenkinsS. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX migraine clinical research group. Headache. 2000;40(6):445-450. Doi:https://doi.org/10.1046/j.1526-4610.2000.00066.x
18.
CarruthersJCarruthersA. Botulinum toxin (botox) chemodenervation for facial rejuvenation. Facial Plast Surg Clin North Am. 2001;9(2):197-vii.
19.
TollefsonTTSendersCMSykesJMByorthPJ. Botulinum toxin to improve results in cleft lip repair. Arch Facial Plast Surg. 2006;8(3):221-222. Doi:https://doi.org/10.1001/archfaci.8.3.221
20.
SterneJACSavovićJPageMJ, et al.Rob 2: A revised tool for assessing risk of bias in randomised trials. Br Med J.2019;366:l4898. doi:https://doi.org/10.1136/bmj.l4898
21.
SlimKNiniEForestierDKwiatkowskiFPanisYChipponiJ. Methodological index for non-randomized studies (minors): Development and validation of a new instrument. ANZ J Surg. 2003;73(9):712-716. doi:https://doi.org/10.1046/j.1445-2197.2003.02748.x
22.
Navarro-BarquínDFLozada-HernándezEETejeda-HernándezM, et al.Use of the type A botulinum toxin in patients submitted to cheiloplasty to improve results in scarring in patients with nonsyndromic cleft lip and palate. Eur J Plast Surg. 2019;42(3):291-294. Doi:https://doi.org/10.1007/s00238-018-1488-y
23.
SonaneJSharmaRKJohnJRSharmaR. Botulinum toxin for a better scar in cleft lip surgery: A prospective randomized control trial. J Craniofac Surg. 2022;33(1):198-202. Doi:https://doi.org/10.1097/SCS.0000000000007836
24.
LuTCBhandariKYaoCFChenPK. The effect of botulinum toxin A in unilateral cleft lip scar: Comparison of results with different sites of injection. Int J Oral Maxillofac Surg. 2022;51(7):900-905. Doi:https://doi.org/10.1016/j.ijom.2021.12.007
25.
ChangCSWallaceCGHsiaoYCChangCJChenPK. Botulinum toxin to improve results in cleft lip repair: A double-blinded, randomized, vehicle-controlled clinical trial. PloS One. 2014;9(12):e115690. Doi:https://doi.org/10.1371/journal.pone.0115690
26.
Photoshop CS5 [Computer software]. Version 12.0. San Jose, California: Adobe Systems Inc, 2010.
GalárragaIM. Use of botulinum toxin in cheiloplasty: A new method to decrease tension. Can J Plast Surg. 2009;17(3):e1-e2. Doi:https://doi.org/10.1177/229255030901700313
29.
LiYHYangJZhengZHuDHWangZD. Botulinum toxin type A attenuates hypertrophic scar formation via the inhibition of TGF-β1/smad and ERK pathways. J Cosmet Dermatol. 2021;20(5):1374-1380. Doi:https://doi.org/10.1111/jocd.13842
30.
JeongHSLeeBHSungHM, et al.Effect of Botulinum toxin type A on differentiation of fibroblasts derived from scar tissue. Plast Reconstr Surg. 2015;136(2):171e-178e. doi:https://doi.org/10.1097/PRS.0000000000001438
31.
WangWLiuGLiX. The efficacy and safety of Botulinum toxin type A injections in improving facial scars: A systematic review and meta-analysis. Pharmacology. 2022;107(5-6):241-249. Doi:https://doi.org/10.1159/000522396
32.
FearmontiRBondJErdmannDLevinsonH. A review of scar scales and scar measuring devices. Eplasty. 2010;10:e43.
DuncanJALBondJSMasonT, et al.Visual analogue scale scoring and ranking: A suitable and sensitive method for assessing scar quality?Plast Reconstr Surg. 2006;118(4):909-918. Doi:https://doi.org/10.1097/01.prs.0000232378.88776.b0
35.
NedelecBShankowskyHATredgetEE. Rating the resolving hypertrophic scar: Comparison of the Vancouver Scar Scale and scar volume. J Burn Care Rehabil. 2000;21(3):205-212. Doi:https://doi.org/10.1067/mbc.2000.104750
36.
MicomonacoDCFungKMountG, et al.Development of a new visual analogue scale for the assessment of area scars. J Otolaryngol Head Neck Surg. 2009;38(1):77-89.
37.
ToulemondePMaltezeanuABroucqsaultHFayouxP. Tolerance of salivary gland botulinum toxin A injection under local anesthesia for the treatment of sialorrhea in children: An observational study. Eur Ann Otorhinolaryngol Head Neck Dis. 2022;139(2):77-81. Doi:https://doi.org/10.1016/j.anorl.2021.06.007
38.
WuSYChangSJYangSSHsuCK. Botulinum toxin injection for medically refractory neurogenic bladder in children: A systematic review. Toxins (Basel). 2021;13(7):447. Doi:https://doi.org/10.3390/toxins13070447
39.
QiuXCuiZTangG, et al.The effectiveness and safety of Botulinum toxin injections for the treatment of congenital muscular torticollis. J Craniofac Surg. 2020;31(8):2160-2166. Doi:https://doi.org/10.1097/SCS.0000000000006652
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
